CClinicalTrials.gg
CompletedNCT06965140Updated May 18, 2025

CP376 OCT Exploratory Skin Study

An interventional study of flat 1-piece open ostomy device in Stoma Ileostomy, sponsored by Coloplast A/S. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-18.

Sponsored by Coloplast A/S · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

An explorative study investigating differences on the peristomal skin and the abdominal skin by Optimal Coherence (OCT) 12 subjects with an ileostomy using a flat 1-piece open ostomy device will be enrolled.

The investigation consists of 2 visits, a screening visit (V0) and a Baseline/test visit (V1). V1 will also terminate the study period .The total study duration will be extended to a maximum of approximately 1 week, depending on the interval between V0 and V1.

Read the detailed description

An explorative study investigating differences on the peristomal skin and the abdominal skin by Optimal Coherence (OCT)

12 subjects with an ileostomy using a flat 1-piece open ostomy device will be enrolled. Subjects will use their standard of care ostomy device as intended and remove the device at the test visit.

The investigation consists of 2 visits, a screening visit (V0) and a Baseline/test visit (V1). V1 will also terminate the study period when the OCT scan and other skin measurements has been completed. The total study duration will be extended to a maximum of approximately 1 week, depending on the interval between V0 and V1.

The OCT scans and other skin measurements (TEWL, Hydration and Erythema measurements) will be performed on the skin when the ostomy device has been removed.

02

Conditions studied

  • Stoma Ileostomy
03

In context

Lead sponsor

Coloplast A/S is the lead sponsor of 146 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Has given written informed consent
  2. Is at least 18 years old
  3. Has full legal capacity
  4. Has an ileostomy
  5. Is using a flat 1-piece open ostomy device
  6. Have had the ileostomy for a year

Exclusion criteria

Exclusion Criteria:

  1. Is currently receiving or have within the past two months received radio-and/or chemotherapy
  2. Is currently receiving or have within the past month received steroid treatment in the skin area used in the investigation, e.g. lotion, spray, injection or tablet
  3. Is pregnant or breastfeeding
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Other
    OCT scan + skin measurements abdominal and peristomal skin

    OCT scan + skin measurements abdominal and peristomal skin

    Device: flat 1-piece open ostomy device

Interventions

  • Deviceflat 1-piece open ostomy device

    OCT scan and skin measurements of peristomal and abdominal skin

06

What researchers measure

Primary outcomes

  1. Thickness of the epidermal layer (assessed by OCT)

    Scan of the peristomal skin

    Time frame: immediately after the OCT scan

07

Study locations

1 site
  • Bispebjerg Hospital, Department of dermatology and venerology
    Copenhagen, 2400, Denmark
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06965140
Lead sponsor
Coloplast A/S
Responsible party
Sponsor
First posted
May 11, 2025
Start date
Apr 7, 2025
Primary completion
May 2, 2025
Completion
May 2, 2025
Last update
May 18, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion